| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 190,920 | 171,200 | 164,419 | 205,248 | | Cost of Revenue | 137,069 | 124,052 | 121,199 | 152,926 | | | Gross Profit | 53,851 | 47,148 | 43,220 | 52,322 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 34,626 | 33,368 | 33,053 | 36,592 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 19,225 | 13,780 | 10,167 | 15,730 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 119 | (1,502) | (1,212) | (3,405) | | Earnings Before Interest And Taxes | 9,945 | 12,278 | 8,955 | 12,325 | | Interest Expense | (6,566) | 3,159 | 3,407 | 3,512 | | Income Before Tax | 16,511 | 9,119 | 5,548 | 8,813 | | Income Tax Expense | 3,271 | 1,546 | 1,571 | 1,217 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 13,665 | 5,939 | 3,969 | (46) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 13,665 | 5,939 | 3,969 | (46) | | Preferred Stock And Other Adjustments | (365) | 158 | 207 |
-
| | | Net Income Applicable To Common Shares | $13,300 | $6,097 | $4,176 | ($46) |
|
0.11% Nasdaq 0.00%
Income Statement
